Agree with you. If the UK trial announcement was a pivot away from the US that would be a major problem. Just don't see any evidence of that being the case.
Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial, page-21
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.003(10.0%) |
Mkt cap ! $33.92M | |||
| Open | High | Low | Value | Volume |
| 2.7¢ | 2.7¢ | 2.7¢ | $6.174K | 228.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 364024 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 292869 | 1 |
View Market Depth
| Last trade - 11.38am 08/08/2024 (20 minute delay) ? |
| RSH (ASX) Chart |